| |
 |
|
|
|
|
|
|
|
|
-
BioDiscovery Releases Nexus Copy Number Version 5.0 for DNA Copy Number Analysis and Visualization
BioDiscovery, Inc. a leader in integrated software solutions for microarray-based research, announced today the release of version 5 of its popular Nexus Copy Number software, the leading platform independent and user friendly application for DNA copy number analysis of microarray derived data.
Read more ...
-
Southeast Surgical, Corp. Wins Scanlan International’s 2009 Southeast Region Sales Representative of the Year Award
Scanlan International awards Southeast Surgical, Corp. “2009 Southeast Region Sales Representative of the Year” at awards ceremony held in Fort Lauderdale, FL.
Read more ...
-
NeuroRepair Validates IP with Lab's Success in New Stroke Therapy
Two recent studies by neuroscientists at the University of California, Irvine, have had startling success with a neuroregenerative therapy tested in rats. The therapy may eventually help restore limb function in people with impaired mobility, long after they have experienced a stroke, traumatic injury, or the onset of neurodegenerative disease, such as Parkinson’s. NeuroRepair owns the Intellectual Property relating to the invention and pending patent applications.
Read more ...
-
Medical Transcription Services and EHR Provider MxSecure Launches New Enhanced Website with Goal of Improved Physician Productivity
MxChart™, Speech Recognition and Stimulus Resource Library featured on redesigned MxSecure, Inc. site: www.mxsecure.com.
Read more ...
-
Neuroimaging Study may Pave way for Effective Alzheimer's Treatments
Scientists have determined that a new instrument known as PIB-PET is effective in detecting deposits of amyloid-beta protein plaques in the brains of living people, and that these deposits are predictive of who will develop Alzheimer’s disease.
Read more ...
-
Dementia Rates Escalate as Brain Capacity Diminishes with Age
The latest report entitled Keeping Dementia Front of Mind highlights the prevalence of the brain condition for governments when making policy and budget decisions. Research has shown brainpower peaks in the mid-twenties and then declines and we lose up to 50% of our brain’s capacity by our mid-fifties. Quincy Bioscience is developing a new approach toward this growing problem.
Read more ...
-
CME Outfitters Announces neuroscienceCME Webcast: 'Epilepsy in the New Millennium: Emerging Treatments and Guidelines for Effective Diagnosis and Disease Management'
This live and interactive CE webcast/teleconference premieres Wednesday, March 24, 2010, from 12:00 p.m.-1:00 p.m. ET, and will highlight the latest evidence for current and emerging treatments and translate guidelines into improved care of patients with epilepsy.
Read more ...
-
Diabetes Clinical Exercise Testing and Prescription for Optimal Rehabilitation Outcomes - A New Physical Therapy Continuing Education Course from North American Seminars
This 2-day, advanced North American Seminars, Inc. course provides practical information pertaining to recent research findings of the use of clinical exercise testing and prescription for people with diabetes to improve functional impairments and prevent complications.
Read more ...
-
Majority of Parkinson’s Patients Improved After German Stem Cell Treatment
The XCell-Center, Europe’s leading stem cell therapy provider has released results from a follow-up study of 50 Parkinson’s disease patients treated with autologous bone marrow stem cells. Overall, almost 60% improved following treatment.
Read more ...
-
Memory Loss Supplement Manufacturer Partners With Nationally-Syndicated Radio Host John Tesh
Quincy Bioscience, manufacturer of Prevagen® - a natural brain health supplement to help fight memory loss http://www.prevagen.com, announces their partnership with nationally-syndicated radio talk show host John Tesh. The unique jellyfish protein-based product was first introduced in 2007 and has helped thousands with their learning, memory, and concentration. A partnership between Quincy Bioscience and The John Tesh Radio Show represents the growing story of a jellyfish protein helping improve brain function for people across the United States.
Read more ...
 |
|
 |
|
|
|
|
|
